Foung; Steven K.H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Foung; Steven K.H..The latest application filed is for "modified hepatitis c virus e2 glycoproteins and methods of use thereof".

Company Profile

0.7.7

Foung; Steven K.H. - College Park MD
Foung; Steven K. H. - Stanford CA
Foung; Steven K. H. - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modified Hepatitis C Virus E2 Glycoproteins And Methods Of Use Thereof App 20220054630 - Pierce; Brian G. ; et al.	2022-02-24
Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins Grant 10,611,827 - Aman , et al.	2020-04-07
Non-human Primate-derived Pan-ebola And Pan-filovirus Monoclonal Antibodies Directed Against Envelope Glycoproteins App 20170334973 - AMAN; Mohammad Javad ; et al.	2017-11-23
Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes Grant 8,114,586 - Foung , et al. February 14, 2	2012-02-14
Prevention and Treatment of HCV Infection Employing Antibodies Directed Against Conformational and Linear Epitopes App 20090202482 - Foung; Steven K. H. ; et al.	2009-08-13
Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes App 20070032635 - Foung; Steven K. H. ; et al.	2007-02-08
Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes App 20060188511 - Foung; Steven K.H. ; et al.	2006-08-24
Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes Grant 7,091,324 - Foung , et al. August 15, 2	2006-08-15
Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes App 20060104980 - Foung; Steven K. H. ; et al.	2006-05-18
Prevention and treatment of HCV infection employing antibodies that inhibit the interaction of HCV virions with their receptor Grant 6,692,908 - Foung , et al. February 17, 2	2004-02-17
Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes App 20030180284 - Foung, Steven K. H. ; et al.	2003-09-25
HTLV-I/HTLV-II assay and method Grant 6,110,662 - Foung , et al. August 29, 2	2000-08-29
Non-human primate monoclonal antibodies and methods Grant 4,777,245 - Foung , et al. October 11, 1	1988-10-11
Human-murine hybridoma fusion partner Grant 4,634,666 - Engleman , et al. January 6, 1	1987-01-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.